$GENI

Genius Sports Ltd

Genius Sports is a business-to-business provider of technology, data and services for sports leagues and federations, sportsbooks, broadcasters, media companies, advertisers and brands. Headquartered in London, it supplies live sports data, video and tracking technology, betting content and services, performance analysis tools, officiating solutions, broadcast enhancements and fan engagement products. Its GeniusIQ platform uses computer vision, machine learning and AI to capture and interpret live sports action. Products include BetVision, an interactive watch-and-bet experience, and advertising and audience tools. Genius earns money by licensing and monetizing sports data and video rights, providing technology and services to customers, and offering advertising solutions. Sportsbook services range from live data feeds and oddsmaking to risk management and back-end operations, with customer arrangements that can include minimum payments and revenue sharing. Advertising is sold through managed campaigns and self-serve packages. The business also provides technology and infrastructure to sports partners, often in exchange for data rights.

No enriched coverage for $GENI in the last 7 days.

—
$184K
Davison Jack
0%
See all $GENI insider activity →
Low

Davison Jack sold $184K of GENI

Davison Jack (Chief Commercial Officer) sold 30,000 shares of Genius Sports Ltd (GENI) at $6.14 ($0.18M total) on 2026-11-12.

JPMorgan reiterates Genius Sports stock rating on solid earnings

JPMorgan maintained an Overweight rating and $8.00 price target on Genius Sports (NYSE:GENI) after its Q3 results. The company reported EBITDA of $87M, 2% above estimates, and raised its fiscal 2026 EBITDA guidance by 1%. Revenue grew 48% over the last year. Goldman Sachs lowered its price target to $9.00 but kept a Buy rating, citing strong revenue growth in the Betting segment.

GENI sentiment & insider activity

Recent GENI coverage spans financial news, earnings and insider activity.

In the last 30 days, GENI insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($184K). The most active reporter was Davison Jack, Chief Commercial Officer, with 1 filing.

What's driving GENI

AlphAI scores every news story that mentions GENI with an AI model for sentiment and relevance, and aggregates insider trades from Genius Sports Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $GENI

Score

JPMorgan reiterates Genius Sports stock rating on solid earnings

JPMorgan maintained an Overweight rating and $8.00 price target on Genius Sports (NYSE:GENI) after its Q3 results. The company reported EBITDA of $87M, 2% above estimates, and raised its fiscal 2026 EBITDA guidance by 1%. Revenue grew 48% over the last year. Goldman Sachs lowered its price target to $9.00 but kept a Buy rating, citing strong revenue growth in the Betting segment.

$GENIHighEarnings

Genius Sports Ltd (GENI): Financial results for Q3 2026

Genius Sports Ltd (GENI) furnished an SEC Form 6-K — earnings release. Exhibit 99.2 Genius Sports Beats Third Quarter Guidance; Raises Full-Year Outlook Delivered $54 Million of Free Cash Flow, 61% Free Cash Flow Conversion, and 32% Group Adjusted EBITDA Margin • Group Revenue of $270m, up 62% year-over-year, vs. guidance of $260m • Income from oper

Genius Sports to deploy offside tech in Argentine football

Genius Sports (NYSE:GENI) expanded its partnership with the Argentine Football Association to introduce semi-automated offside technology in Argentina's top-flight football league. The system, which reduces offside decision times by over 30%, will launch in December 2026 and be fully deployed by July 2027. The technology uses AI and camera tracking to assist referees and provide real-time visualizations.

Genius, CF, 3M, Nike, Synopsys Trending With Analysts

Analysts cover five stocks: Genius Sports (GENI) with a $8 target, CF Industries (CF) with a $162 target, 3M (MMM) upgraded to Hold with a $171 target, Nike (NKE) downgraded to Sell with a $30 target, and Synopsys (SNPS) upgraded to Buy with a $700 target. Analysts cite growth, valuation, and market conditions as key factors.

Related tickers